sun
biopharma
inc
schedules
conference
call
november
report
third
quarter
financial
results
minneapolis
globe
newswire
sun
biopharma
nasdaq
snbp
clinical
stage
biopharmaceutical
company
developing
disruptive
therapeutics
treatment
patients
pancreatic
cancer
today
announced
host
conference
call
november
pm
eastern
time
discuss
results
third
quarter
ended
september
conference
call
information
participate
event
dial
approximately
minutes
beginning
call
date
november
time
pm
eastern
time
toll
free
international
call
also
available
internet
accessible
https
webcast
page
conference
call
replay
information
toll
free
international
replay
passcode
proprietary
polyamine
analogue
designed
induce
polyamine
metabolic
inhibition
pmi
exploiting
observed
high
affinity
compound
exocrine
pancreas
pancreatic
ductal
adenocarcinoma
molecule
shown
signals
tumor
growth
inhibition
clinical
studies
us
australian
metastatic
pancreatic
cancer
patients
suggesting
complementary
activity
existing
chemotherapy
regimen
clinical
studies
date
shown
exacerbation
typical
adverse
events
bone
marrow
suppression
peripheral
neuropathy
safety
data
pmi
profile
observed
sun
biopharma
current
clinical
trial
provides
support
continued
evaluation
compound
randomized
clinical
trial
sun
biopharma
sun
biopharma
biopharmaceutical
company
developing
disruptive
therapeutics
patients
urgent
unmet
medical
needs
company
initial
product
candidate
treatment
patients
metastatic
pancreatic
ductal
adenocarcinoma
common
type
pancreatic
cancer
sun
biopharma
dedicated
treating
patients
pancreatic
cancer
fully
exploring
potential
efficacy
combination
agents
treating
types
cancer
invented
raymond
bergeron
distinguished
professor
emeritus
university
florida
sun
biopharma
scientific
collaborations
pancreatic
disease
experts
cedars
sinai
medical
center
los
angeles
university
rochester
new
york
scripps
md
anderson
cancer
center
san
diego
california
university
florida
austin
health
cancer
trials
centre
melbourne
australia
ashford
cancer
centre
adelaide
australia
blacktown
cancer
haemotology
centre
sydney
australia
john
flynn
private
hospital
tugun
queensland
australia
company
independent
data
safety
monitoring
board
dsmb
chaired
james
abbruzzese
md
professor
medicine
chief
division
medical
oncology
duke
university
school
medicine
professor
david
goldstein
fracp
senior
staff
specialist
prince
henry
prince
wales
hospital
cancer
care
centre
sydney
australia
dsmb
information
found
sun
biopharma
common
stock
listed
nasdaq
capital
market
symbol
snbp
contact
information
investors
james
carbonara
hayden
ir
james
media
tammy
groene
sun
biopharma
